- COVID-19
- Biosimilars
- Cataract Therapeutics
- DME
- Gene Therapy
- Workplace
- Ptosis
- Optic Relief
- Imaging
- Geographic Atrophy
- AMD
- Presbyopia
- Ocular Surface Disease
- Practice Management
- Pediatrics
- Surgery
- Therapeutics
- Optometry
- Retina
- Cataract
- Pharmacy
- IOL
- Dry Eye
- Understanding Antibiotic Resistance
- Refractive
- Cornea
- Glaucoma
- OCT
- Ocular Allergy
- Clinical Diagnosis
- Technology
Researcher receives funding support from Research to Prevent Blindness
Philip Ruzycki, PhD, receives a career development award that will provide $350,000 to support his laboratory over the next 4 years.
Philip Ruzycki, PhD, an assistant professor in the John F. Hardesty, MD, Department of Ophthalmology and Visual Sciences, at Washington University School of Medicine in St. Louis, has received a career development award from Research to Prevent Blindness.
Philip Ruzycki, PhD
The award provides $350,000 to support Ruzycki’s laboratory over the next 4 years
The award is given to support the independent pursuits of promising basic scientists and clinician-scientists who are early in their careers and who study the visual system. Ruzycki’s research applies molecular genetics techniques, along with computational biology, to analyze the genomic, proteomic and transcriptomic aspects that drive retinal development and disease.
Ruzycki is a graduate of the Molecular Genetics and Genomics program in Washington University’s Division of Biology & Biomedical Sciences (DBBS). He serves as a co-director of the ophthalmology department’s Biostatistics & Bioinformatics Core.
